BioMarin is a world leader in developing and commercializing innovative therapies for rare diseases driven by genetic causes. With a 20-year history, BioMarin remains steadfast to its original mission—to bring new treatments to market that will make a big impact on small patient populations. These conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options, and are usually ignored. BioMarin is committed to servicing the needs of patients, families, and physicians by providing rapid access to therapeutic treatment, disease education, and support services. Follow us on Facebook or YouTube to learn more.